;or a pharmaceutically acceptable salt thereof; in combination with an effective amount of an anti-N3pGlu Aβ monoclonal antibody. Moreover, the present invention provides a kit for treating Alzheimer's disease, comprising said compound and monoclonal antibody, as well as the use thereof for treating the mentioned disease."/>
公开/公告号EA031764B1
专利类型
公开/公告日2019-02-28
原文格式PDF
申请/专利权人 ELI LILLY AND COMPANY;
申请/专利号EA20170090305
申请日2015-09-08
分类号A61K31/542;C07D513/04;C07K16/18;A61K39/395;
国家 EA
入库时间 2022-08-21 12:02:31